Prolonged Circulating Lipid Nanoparticles Enabled by High-Density Gd-DTPA-Bis(stearylamide) for Long-Lasting Enhanced Tumor Magnetic Resonance Imaging
- 28 October 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 33 (11) , 2213-2222
Abstract
Porphysomes (PS) were explored to incorporate different types of diethylenetriaminepentaacetic-acid-gadolinium-(III) (Gd-DTPA)-lipids into their bilayer membrane to assess PS potential as an MRI contrast agent. The Gd-dPS-BSA by integration of over 30% Gd-DTPA-bis(stearylamide) (Gd-DTPA-BSA)-lipids in PS construction resulted in exceptional serum stability and T1 and T2 relaxivity measurements of 13 mM-1 s-1 and 19 mM-1 s-1, respectively. The Gd-dPS-BSA demonstrated significantly enhanced retention in blood circulation with a half-life of 13.6 h and high tumor accumulation up to 19.5%ID/g at 72 h post-injection in select cancer mouse models. Additionally, Gd-dPS-BSA displayed excellent MRI tumor enhancement over 24, 48, and 72 h with contrast enhancements from the baseline of 35.8%, 38.2%, and 38.3%, respectively. Results reported here highlight a high-density incorporation of Gd-DTPA-BSA-lipids within PS, and other liposome formulations can enhance circulatory longevity, independently of particles' concentration, suggesting effective MRI contrast agent potential for Gd-dPS-BSA and potential utility of Gd-DTPA-BSA-lipids to enhance other liposomal-influenced diagnostic and therapeutic functions.Keywords
Funding Information
- Canadian Institutes of Health Research (FDN154326)
- Canada Foundation for Innovation
- Canada Research Chairs
- Terry Fox Research Institute (1081)
- Princess Margaret Cancer Foundation
- Natural Sciences and Engineering Research Council of Canada (RGPIN-03688)
This publication has 27 references indexed in Scilit:
- Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agentsNature Materials, 2011
- Protein-Based MRI Contrast Agents for Molecular Imaging of Prostate CancerMolecular Imaging and Biology, 2010
- Higher Liposomal Membrane Fluidity Enhances the in Vitro Antitumor Activity of Folate-Targeted Liposomal MitoxantroneMolecular Pharmaceutics, 2008
- Focal liver lesions: Whether a standard dose (0.05mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1mmol/kg doseEuropean Journal of Radiology, 2008
- Annexin A5-Functionalized Bimodal Lipid-Based Contrast Agents for the Detection of ApoptosisBioconjugate Chemistry, 2006
- Relaxivity of liposomal paramagnetic MRI contrast agentsMagnetic Resonance Materials in Physics, Biology and Medicine, 2005
- Gadolinium DTPA‐Monoamide Complexes Incorporated into Mixed Micelles as Possible MRI Contrast AgentsEuropean Journal of Inorganic Chemistry, 2004
- The Effect of Different Lipid Components on the In Vitro Stability and Release Kinetics of Liposome FormulationsDrug Delivery, 2004
- Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animalsAdvanced Drug Delivery Reviews, 1997
- Pharmacokinetics of long-circulating liposomesAdvanced Drug Delivery Reviews, 1995